Education
About Us
Working with TipRanks
Follow Us
Tonix Pharma (TNXP)
NASDAQ:TNXP
Total Valuation
Tonix Pharma has a market cap or net worth of $118.99M. The enterprise value is -$10.32M.
Market Cap$118.99M
Enterprise Value-$10.32M
Share Statistics
Tonix Pharma has 6.88M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6.88M
Owened by Insiders<0.01%
Owened by Instutions0.10%
Financial Efficiency
Tonix Pharma’s return on equity (ROE) is -0.93 and return on invested capital (ROIC) is -92.57%.
Return on Equity (ROE)-93.18%
Return on Assets (ROA)-79.83%
Return on Invested Capital (ROIC)-92.57%
Return on Capital Employed (ROCE)-94.55%
Revenue Per Employee$124,617.284
Profits Per Employee-$1,605,382.716
Employee Count81
Asset Turnover0.06
Inventory Turnover0.92
Valuation Ratios
The current PE Ratio of Tonix Pharma is -0.19. Tonix Pharma’s PEG ratio is <0.01.
PE Ratio-0.19
PS Ratio2.41
PB Ratio0.17
Price to Fair Value0.17
Price to FCF-0.40
Price to Operating Cash Flow-0.40
PEG Ratio<0.01
Income Statement
In the last 12 months, Tonix Pharma had revenue of $10.09M and earned -$130.04M in profits. Earnings per share was -$1002.14.
Revenue$10.09M
Gross Profit$2.33M
Operating Income-$77.74M
Pretax Income-$129.99M
Net Income-$130.04M
EBITDA-74.38M
Earnings Per Share (EPS)-1.00K
Cash Flow
In the last 12 months, operating cash flow was -$60.47M and capital expenditures -$120.00K, giving a free cash flow of -$61.05M billion.
Operating Cash Flow-$60.47M
Free Cash Flow-$61.05M
Free Cash Flow per Share-$8.88
Dividends & Yields
Tonix Pharma pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-251.37%
Earnings Yield-535.47%
Stock Price Statistics
Beta0.78
52-Week Price Change-96.38%
50-Day Moving Average15.70
200-Day Moving Average27.65
Relative Strength Index (RSI)47.53
Average Volume (3m)2.04M
Important Dates
Tonix Pharma upcoming earnings date is May 12, 2025, Before Open.
Last Earnings DateMar 18, 2025
Next Earnings DateMay 12, 2025
Ex-Dividend Date―
Financial Position
Tonix Pharma as a current ratio of 6.50, with Debt / Equity ratio of 0.06
Current Ratio6.50
Quick Ratio6.04
Debt to Market Cap0.33
Net Debt to EBITDA1.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Tonix Pharma has paid -$1.17M in taxes.
Income Tax-$1.17M
Effective Tax Rate0.00%
Enterprise Valuation
Tonix Pharma EV to EBITDA ratio is 0.93, with an EV/FCF ratio of 1.09.
EV to Sales-6.58
EV to EBITDA0.93
EV to Free Cash Flow1.09
EV to Operating Cash Flow1.09
Balance Sheet
Tonix Pharma has $98.78M in cash and marketable securities with $5.30M in debt, giving a net cash position of -$93.48M billion.
Cash & Marketable Securities$98.78M
Total Debt$5.30M
Net Cash-$93.48M
Net Cash Per Share-$13.59
Tangible Book Value Per Share$189.37
Margins
Gross margin is 23.07%, with operating margin of -1354.28%, and net profit margin of -1288.25%.
Gross Margin23.07%
Operating Margin-1354.28%
Pretax Margin-1288.25%
Net Profit Margin-1288.25%
EBITDA Margin-710.61%
EBIT Margin-744.50%
Analyst Forecast
The average price target for Tonix Pharma is $70.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$70.00
Price Target Upside314.69%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast29.94%
EPS Growth Forecast-241.81%